chrX-54809737-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000375068.6(MAGED2):āc.61A>Gā(p.Lys21Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000276 in 1,087,466 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000375068.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED2 | NM_177433.3 | c.61A>G | p.Lys21Glu | missense_variant | 3/13 | ENST00000375068.6 | NP_803182.1 | |
MAGED2 | NM_014599.6 | c.61A>G | p.Lys21Glu | missense_variant | 3/13 | NP_055414.2 | ||
MAGED2 | NM_201222.3 | c.61A>G | p.Lys21Glu | missense_variant | 3/13 | NP_957516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED2 | ENST00000375068.6 | c.61A>G | p.Lys21Glu | missense_variant | 3/13 | 1 | NM_177433.3 | ENSP00000364209 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 111523Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33689 FAILED QC
GnomAD3 exomes AF: 0.00000586 AC: 1AN: 170701Hom.: 0 AF XY: 0.0000176 AC XY: 1AN XY: 56753
GnomAD4 exome AF: 0.00000276 AC: 3AN: 1087466Hom.: 0 Cov.: 31 AF XY: 0.00000563 AC XY: 2AN XY: 355220
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 111523Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33689
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 22, 2023 | This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 21 of the MAGED2 protein (p.Lys21Glu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MAGED2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1985219). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at